Search
Filter Results
- Resource Type
- Article1
- Journal1
- Journal Digital1
- Statistics1
- Article Type
- Clinical Trial1
- Clinical Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Eur Urol1
Search Results
Sort by
- JournalDigital AccessProviderVersionGoogle BooksGoogle BooksGoogle BooksGoogle BooksGoogle Books
- ArticleDonkervoort T, Sterling A, van Ness J, Donker PJ.Eur Urol. 1977;3(4):218-25.20 patients with benign prostatic hypertrophy were admitted to a double-blind noncrossover study for evaluation of the effect of Tadenan. Using either standard clinical criteria or urodynamic data obtained by the urinary drop spectrometer, no significant effect was found for the dosage and period of administration used.